维普中文期刊产品整合服务
127篇 您的检索式:作者名="HIV"
    题名 作者 年代 出处 被引量
1人类免疫缺陷病毒感染/艾滋病合并结核分枝杆菌感染诊治专家共识显示文摘2017年,中华医学会感染病学分会艾滋病学组和中华医学会热带病与寄生虫学分会艾滋病学组共同制订并发布了第一版《HIV合并结核分枝杆菌感染诊治专家共识》。2021年,中国性病艾滋病防治协会HIV合并结核病专业委员会组织相关专家对第一版共识进行了修订更新。新版共识更新了人类免疫缺陷病毒感染/艾滋病患者结核病预防性治疗、结核病的分子诊断、耐药结核病的治疗、抗反转录病毒治疗启动时机与方案、结核相关免疫重建炎症综合征的诊断及处理、不良反应等方面的进展。本共识将根据最新临床研究证据定期进行更新。中国性病艾滋病防治协会HIV合并结核病专业委员会 沈银忠 卢洪洲 2022新发传染病电子杂志2022,7,1:18
21997年全国艾滋病哨点监测报告显示文摘1997年,全国HIV监测哨点共调整为60个,分布在27个省(自治区、直辖市)。性病门诊哨点和长卡哨点中只检出极少数HIV感染者。1997年,在3个暗娼哨点中的检出率约为1%~2%,而1996年同期仅为不到0.5%;在12个吸毒哨点中有7个哨点(包括2个新增哨点)报告了HIV感染者,而在1996年同期8个哨点中有3个哨点报告了感染者。新疆自治区报告了83例(20.8%)感染者,而在前几年同期同一哨点只有32例(8.0%)。在大部分吸毒监测哨点中的静注比例正不断增加或保持一个较高水平。暗娼人群中有60%从不使用避孕套。该监测结果表明,局部地区吸毒者中HIV感染率在不断上升,HIV波及的地区在不断地增多,HIV感染已开始向性乱人群扩散;可引起HIV流行的危险因素在不断增加。Department of Disease Control,Ministry of Health,People′s Republic of China 1 Center for AIDS Surveillance,Chinese Academy of Preventive Medicine 2 Group of National HIV Sentinel Surveillance Program (Written by Qu Shuquan 2,Sun Xinhua 1,Zheng X 1998中国性病艾滋病防治1998,4,4:15
3人类免疫缺陷病毒感染/艾滋病合并结核分枝杆菌感染诊治专家共识显示文摘2017年,中华医学会感染病学分会艾滋病学组和中华医学会热带病与寄生虫学分会艾滋病学组共同制订并发布了第1版《HIV合并结核分枝杆菌感染诊治专家共识》。2021年,中国性病艾滋病防治协会HIV合并结核病专业委员会组织相关专家对第1版共识进行了修订和更新。新版共识更新了人类免疫缺陷病毒感染/艾滋病患者的结核病预防性治疗、结核病的分子诊断、耐药结核病的治疗、抗反转录病毒治疗启动时机与方案、结核相关免疫重建炎症综合征的诊断及处理、不良反应等方面的进展。本共识将根据最新临床研究证据定期进行更新。中国性病艾滋病防治协会HIV合并结核病专业委员会 沈银忠 卢洪洲 2022中华传染病杂志2022,40,1:13
41996年中国艾滋病哨点监测报告显示文摘我国自1995年开始在23个省(自治区、直辖市)的42个哨点中对性传播疾病(STDs)门诊就诊者、暗娼、吸毒者和长途卡车司机四类人群进行监测,当年监测结果显示,在监测哨点所在的城市中,被监测的STDs门诊就诊者、暗娼、吸毒者和长途卡车司机人群中HIV感染率均很低,但存在广泛传播的危险性。1996年第一轮共监测10085人,发现HIV感染者35例。其中在STDs门诊就诊者中发现HIV感染者1例,在吸毒者中发现HIV感染者34例(其中新疆32例);第二轮监测11909人,发现HIV感染者72例,其中在暗娼人群中发现1例,在吸毒人群中发现71例(其中新疆69例)。1996年监测结果表明,在哨点所在的城市中,尽管被监测的STDs门诊就诊者、暗娼和长途卡车司机人群中HIV感染率仍很低,但我国HIV流行形势已发生改变,HIV感染的流行已不仅仅局限于云南吸毒者中,在其它地区已开始在吸毒者中流行,个别地区该人群中HIV感染率上升很快。Department of Disease control.Ministry of Health,People′s Republic of China 1 Center for AIDS Surveillance,Chinese Academy of Preventive Medicine 2 Group of National HIV sentinel surveillance program (Written by Qu Shuquan 2,Sun Xinhua 1,Zheng Xiwen 1997中国性病艾滋病防治1997,3,5:12
5Circulating miRNA and cancer diagnosis显示文摘miRNAs are a class of small RNA molecules with regulatory function, and play an important role in tumor development and progression. It has been demonstrated that tumor-derived miRNAs exist in the circulating nucleic acids of cancer patients. This phenomenon implies that detection of the circulating miRNA may be an effective method for non-invasive diagnosis of cancer. In this review, we summarize the applications of the circulating miRNA as biomarkers in cancer diagnosis, as well as the latest research progress in this area.TIE Yi1, LIU BinDong2, FU HanJiang1 & ZHENG XiaoFei1· 1 Beijing Institute of Radiation Medicine, Bejing 100850, China 2 Health Disparities/HIV Immed Ofc, Meharry Medical College, Nashville TN 37208, USA 2009Science China(Life Sciences)2009,52,12:9
6Late postnatal transmission of HIV - 1 in breast - fed children : an individual patient data meta-analysis 显示文摘The Breastfeeding and HIV International Transmission Study Group 2004J Infect Dis2004,189,12:1
7Analysis of prevalence of HIV-1 drug resistance in primary infections in the United Kingdom显示文摘UK Collaborative Group on Monitoring the Transmission of HIV Drug Resistance 2001BMJ2001,322,:1
8Osteoporotic vertebral burst fractures with neuologic compromise显示文摘Nauyen HIV Ludwing S Gelb D 2003J Spine Disored Tech2003,16,:1
9Rates of mother-to-child transmission of HIV-1 in Africa,America and Europe 显示文摘Working Group on Mother-to-Child Transmission of HIV 1995J Acquir Immune Defic Syndr Hum Retrovirol1995,8,:1
10Screening, recruiting and predicting retention of participants in a multisite HIV prevention trial显示文摘NIMH Multisite HIV Prevention Trial 1997AIDS1997,11,2:1
11The major genetic determinants of HIV-1control affect HLA class I peptide presentation显示文摘International HIV Controllers Study Pereyra F Jia X McLaren P J Telenti A de Bakker P I Walker B D Ripke S Brumme C J Pulit S L Carrington M Kadie C M Carlson J M Heckerman D Graham R R Plenge R M Deeks S G Gianniny L Crawford G Sullivan J Gonzalez E Davies L Camargo A Moore JM Beattie N Gupta S Crenshaw A Burtt N P Guiducci C Gupta N Gao X Qi Y Yuki Y Piechocka-Trocha A Cutrell E Rosenberg R Moss K L Lemay P O'Leary J Schaefer T Verma P Toth I Block B Baker B Rothchild A Lian J Proudfoot J Alvino D M Vine S Addo M M Allen T M Altfeld M Henn M R Le Gall S Streeck H Haas D W Kuritzkes D R Robbins G K Shafer R W Gulick R M Shikuma C M Haubrich R Riddler S Sax P E Daar E S Ribaudo H J Agan B Agarwal S Ahern R L Allen B L Altidor S Altschuler E L Ambardar S Anastos K Anderson B Anderson V Andrady U Antoniskis D Bangsberg D Barbaro D Barrie W Bartczak J Barton S Basden P Basgoz N Bazner S Bellos N C Benson A M Berger J Bernard N F Bernard A M Birch C Bodner S J Bolan R K Boudreaux E T Bradley M Braun J F Brndjar J E Brown S J Brown K Brown S T Burack J Bush LM Cafaro V Campbell O Campbell J Carlson R H Carmichael J K Casey K K Cavacuiti C Celestin G Chambers S T Chez N Chirch L M Cimoch P J Cohen D Cohn LE Conway B Cooper D A Cornelson B Cox D T Cristofano M V Cuchural G Jr Czartoski J L Dahman J M Daly J S Davis B T Davis K Davod S M DeJesus E Dietz C A Dunham E Dunn M E Ellerin T B Eron J J Fangman J J Farel C E Ferlazzo H Fidler S Fleenor-Ford A Frankel R Freedberg K A French N K Fuchs JD Fuller J D Gaberman J Gallant J E Gandhi R T Garcia E Garmon D Gathe J C Jr Gaultier C R Gebre W Gilman F D Gilson I Goepfert P A Gottlieb M S Goulston C Groger R K Gurley T D Haber S Hardwicke R Hardy W D Harrigan P R Hawkins T N Heath S Hecht F M Henry W K Hladek M Hoffman R P Horton J M Hsu R K Huhn G D Hunt P Hupert M J Illeman M L Jaeger H Jellinger R M John M Johnson J A Johnson K L Johnson H Johnson K Joly J Jordan W C Kauffman C A Khanlou H Killian R K Kim A Y Kim D D Kinder C A Kirchner J T Kogelman L Kojic E M Korthuis P T Kurisu W Kwon D S LaMar M Lampiris H Lanzafame M Lederman M M Lee D M Lee J M Lee M J Lee E T Lemoine J Levy J A Llibre J M Liguori M A Little S J Liu A Y Lopez A J Loutfy M R Loy D Mohammed D Y Man A Mansour M K Marconi V C Markowitz M Marques R Martin J N Martin H L Jr Mayer K H McElrath M J McGhee T A McGovern B H McGowan K McIntyre D Mcleod GX Menezes P Mesa G Metroka CE Meyer-Olson D Miller A O Montgomery K Mounzer K C Nagami E H Nagin I Nahass R G Nelson M O Nielsen C Norene D L O'Connor D H Ojikutu B O Okulicz J Oladehin O O Oldfield E C Olender S A Ostrowski M Owen WF Jr Pae E Parsonnet J Pavlatos A M Perlmutter A M Pierce M N Pincus J M Pisani L Price L J Proia L Prokesch R C Pujet H C Ramgopal M Rathod A Rausch M Ravishankar J Rhame F S Richards C S Richman D D Rodes B Rodriguez M Rose R C 3rd Rosenberg E S Rosenthal D Ross P E Rubin D S Rumbaugh E Saenz L Salvaggio M R Sanchez WC Sanjana V M Santiago S Schmidt W Schuitemaker H Sestak P M Shalit P Shay W Shirvani V N Silebi V I Sizemore J M Jr Skolnik P R Sokol-Anderson M Sosman J M Stabile P Stapleton J T Starrett S Stein F Stellbrink H J Sterman FL Stone V E Stone D R Tambussi G Taplitz R A Tedaldi E M Telenti A Theisen W Torres R Tosiello L Tremblay C Tribble M A Trinh P D Tsao A Ueda P Vaccaro A Valadas E Vanig T J Vecino I Vega V M Veikley W Wade B H Walworth C Wanidworanun C Ward D J Warner D A Weber R D Webster D Weis S Wheeler D A White D J Wilkins E Winston A Wlodaver C G van't Wout A Wright D P Yang O O Yurdin D L Zabukovic B W Zachary K C Zeeman B Zhao M 2010Science2010,330,6010:1
12Duration of ruptured membranes and vertical transmission of HIV - 1 : a meta - analysis from 15 prospective cohort studies 显示文摘International Perinatal HIV Group 2001AIDS2001,15,3:1
13Correlates of protective cellular immunity revealed by analysis of population-level immune escape pathways in HIV-1显示文摘Carlson J M Brumme C J Martin E Listgarten J Brockman M A Le A Q Chui C K Cotton L A Knapp D J Riddler S A Haubrich R Nelson G Pfeifer N Deziel C E Heckerman D Apps R Carrington M Mallal S Harrigan P R John M Brumme Z L International HIV Adaptation Collaborative 2012J Virol2012,86,13:1
14The mode of delivery and the risk of vertical transmission of HIV type 1:a meta-analysis of 15 prospective cohort studies显示文摘International Perinatal HIV Group 1999N Engl J Med1999,340,:1
15Fine-mapping classical HLA variation associated with durable host control of HIV-1infection in African Americans显示文摘McLaren P J Ripke S Pelak K Weintrob A C Patsopoulos N A Jia X Erlich R L Lennon N J Kadie C M Heckerman D Gupta N Haas D W Deeks S G Pereyra F Walker B D de Bakker P I International HIV Controllers Study 2012Hum Mol Genet2012,21,19:1
16Centers for Disease Control and Prevention显示文摘Public health service guidelines for the management of health-care worker exposures to HIV and resommendations for postex-posure prophylaxis 1998MMWR Recomm Rep1998,47,7:1
17Predictors of fexual behavior patterns over one yeat among persons at high risk for HIV显示文摘The national institute of mental health(NIMH) multisite HIV prevention trial group 2002Arch Sex Beh2002,21,2:1
18Analysis of prevalence of HIV-1 drug resistance in primary infections in the United Kingdom显示文摘UK Collaborative Group on Monitoring the Transmission of HIV Drug Resistance 2001BMJ2001,322,:1
19Osteoporotie verte- bral burst fractures with neuologic compromise 显示文摘Nguyen HIV Ludwing S Gelb D 2003Spine Disored Teeh2003,16,1:1
20Time trend in primary resistance to HIV drug in the United Kingdom:multicentre observational study显示文摘UK Group on Transmitted of HIV Drug Resistance 2005BMJ2005,331,:1
返回顶部 每页显示:
共7页 首页 上一页 第1页 下一页 末页 /7 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费